On Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved 73 grants totaling almost $154 million. To date, CPRIT’s total investment in cancer prevention and research tops $4 billion—more than any other state in the nation. CPRIT, which marked the 18th anniversary of the statewide vote that launched the agency this month, stands as the second-largest funder of cancer research in the country after the National Cancer Institute.

During the meeting, the board approved grants that advance every part of the fight against cancer—from basic research and prevention to product development and innovation.

The Oversight Committee approved a $4 million Texas Device and Diagnostics Company Award for ExoDiscovery Technologies, a Cedar Park company developing a new blood test for non-small cell lung cancer (NSCLC), the most common form of lung cancer.

The board also approved a $1.4 million prevention grant to the Young Women’s Christian Association (YWCA) of San Antonio for its “From Doorstep to Diagnosis” program. The program helps underserved women in Bexar County access breast and cervical cancer screenings and builds long-term connections to primary care.

Created by the Texas Legislature and approved by a statewide vote in 2007, the Cancer Prevention and Research Institute of Texas (CPRIT) leads the Lone Star State’s fight against cancer. In 2019, Texas voters again voted overwhelmingly to support CPRIT with an additional $3 billion, for a total $6 billion investment in cancer research and prevention.